TAKEDA PHARMACEUTICAL CO LTD 4
4 · Phathom Pharmaceuticals, Inc. · Filed Mar 16, 2022
Insider Transaction Report
Form 4
TAKEDA PHARMACEUTICAL CO LTD
10% Owner
Transactions
- Exercise of In-Money
Common Stock
2022-03-14+7,359,304→ 7,459,304 total - Exercise of In-Money
Warrants
2022-03-14−7,359,304→ 0 totalExercise: $0.00From: 2019-10-29Exp: 2029-05-07→ Common Stock (7,359,304 underlying) - Sale
Common Stock
2022-03-14$19.00/sh−18$342→ 7,459,286 total
Footnotes (1)
- [F1]On March 14, 2022, the Reporting Person exercised a Warrant to purchase 7,359,304 shares of the Issuers common stock with an exercise price of $0.00004613 per share. The Reporting Person paid the exercise price on a cashless basis in accordance with the terms of such Warrants, resulting in the Issuer withholding a number of shares (or portion thereof) to satisfy the exercise price and issuing to the Reporting Person the remaining number of shares. The Issuer also paid the Reporting Person $2.52 in lieu of a fractional share.